ALEXANDRIA, Va., June 4 -- United States Patent no. 12,318,367, issued on June 3, was assigned to AstraZeneca AB (Sodertalje, Sweden) and Array BioPharma Inc. (Boulder, Colo.).
"Pharmaceutical composition" was invented by Nicola Frances Bateman (Macclesfield, Great Britain), Paul Richard Gellert (Macclesfield, Great Britain) and Kathryn Jane Hill (Macclesfield, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention concerns pharmaceutical compositions containing a hydrogen sulphate salt of 6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide and solvates, crystalline forms and amorphous forms thereof, to the use of said compositio...